AIM: Both observational and experimental studies have shown that higher selenium status reduces the risk of upper gastrointestinal cancers in selenium deficient populations. Recent cancer registry data have shown very different rates of esophageal cancer (EC) and gastric cancer (GC) in four Provinces of Iran, namely Ardabil, Mazandaran, Golestan, and Kerman. The aim of this study was to have a preliminary assessment of the hypothesis that high rates of EC in Golestan and high rates of GC in Ardabil may be partly attributable to selenium deficiency. METHODS: We measured serum selenium in 300 healthy adults from Ardabil (n = 100), Mazandaran (n = 50), Golestan (n = 100), and Kerman (n = 50), using inductively coupled plasma, with dynamic reaction cell, mass spectrometry (ICP-DRC-MS) at the US Centers for Disease Control (Atlanta, Georgia). RESULTS: The median serum selenium concentrations were very different in the four Provinces. The medians (IQR) for selenium in Ardabil, Mazandarn, Golestan, and Kerman were 82 (75-94), 123 (111-132), 155 (141-173), and 119 (110-128) microg/L, respectively (P<0.001). The results of linear regression showed that the Province variable, by itself, explained 76% of the variance in log selenium (r2 = 0.76). The proportion of the populations with a serum selenium more than 90 microg/L (the concentration at which serum selenoproteins are saturated) was 100% in Golestan, Kerman, and Mazandaran but only 29% in Ardabil. CONCLUSION: Our findings suggest that selenium deficiency is not a major contributor to the high incidence of EC seen in northeastern Iran, but it may play a role in the high incidence of GC in Ardabil Province. Copyright 2004 The WJG Press ISSN
AIM: Both observational and experimental studies have shown that higher selenium status reduces the risk of upper gastrointestinal cancers in selenium deficient populations. Recent cancer registry data have shown very different rates of esophageal cancer (EC) and gastric cancer (GC) in four Provinces of Iran, namely Ardabil, Mazandaran, Golestan, and Kerman. The aim of this study was to have a preliminary assessment of the hypothesis that high rates of EC in Golestan and high rates of GC in Ardabil may be partly attributable to selenium deficiency. METHODS: We measured serum selenium in 300 healthy adults from Ardabil (n = 100), Mazandaran (n = 50), Golestan (n = 100), and Kerman (n = 50), using inductively coupled plasma, with dynamic reaction cell, mass spectrometry (ICP-DRC-MS) at the US Centers for Disease Control (Atlanta, Georgia). RESULTS: The median serum selenium concentrations were very different in the four Provinces. The medians (IQR) for selenium in Ardabil, Mazandarn, Golestan, and Kerman were 82 (75-94), 123 (111-132), 155 (141-173), and 119 (110-128) microg/L, respectively (P<0.001). The results of linear regression showed that the Province variable, by itself, explained 76% of the variance in log selenium (r2 = 0.76). The proportion of the populations with a serum selenium more than 90 microg/L (the concentration at which serum selenoproteins are saturated) was 100% in Golestan, Kerman, and Mazandaran but only 29% in Ardabil. CONCLUSION: Our findings suggest that selenium deficiency is not a major contributor to the high incidence of EC seen in northeastern Iran, but it may play a role in the high incidence of GC in Ardabil Province. Copyright 2004 The WJG Press ISSN
Authors: S D Mark; Y L Qiao; S M Dawsey; Y P Wu; H Katki; E W Gunter; J F Fraumeni; W J Blot; Z W Dong; P R Taylor Journal: J Natl Cancer Inst Date: 2000-11-01 Impact factor: 13.506
Authors: Wen-Qiang Wei; Christian C Abnet; You-Lin Qiao; Sanford M Dawsey; Zhi-Wei Dong; Xiu-Di Sun; Jin-Hu Fan; Elaine W Gunter; Philip R Taylor; Steven D Mark Journal: Am J Clin Nutr Date: 2004-01 Impact factor: 7.045
Authors: P Knekt; A Aromaa; J Maatela; G Alfthan; R K Aaran; M Hakama; T Hakulinen; R Peto; L Teppo Journal: J Natl Cancer Inst Date: 1990-05-16 Impact factor: 13.506
Authors: Alireza Sadjadi; Reza Malekzadeh; Mohammad H Derakhshan; Alireza Sepehr; Mehdi Nouraie; Masoud Sotoudeh; Abbas Yazdanbod; Behrooz Shokoohi; Afshin Mashayekhi; Shahnam Arshi; Ali Majidpour; Masoud Babaei; Alireza Mosavi; Mohammad Ali Mohagheghi; Masomeh Alimohammadian; Mohammad Ali Mohagheghi Mosavi Journal: Int J Cancer Date: 2003-10-20 Impact factor: 7.396
Authors: F Saidi; A Sepehr; S Fahimi; M J Farahvash; P Salehian; A Esmailzadeh; M Keshoofy; N Pirmoazen; M Yazdanbod; M K Roshan Journal: Br J Cancer Date: 2000-11 Impact factor: 7.640
Authors: Akram Pourshams; Hooman Khademi; Akbar Fazeltabar Malekshah; Farhad Islami; Mehdi Nouraei; Ali Reza Sadjadi; Elham Jafari; Nasser Rakhshani; Rasool Salahi; Shahryar Semnani; Farin Kamangar; Christian C Abnet; Bruce Ponder; Nick Day; Sanford M Dawsey; Paolo Boffetta; Reza Malekzadeh Journal: Int J Epidemiol Date: 2009-03-30 Impact factor: 7.196
Authors: Sadaf G Sepanlou; Arash Etemadi; Farin Kamangar; Alireza Sepehr; Akram Pourshams; Hossein Poustchi; Farhad Islami; Alireza Sadjadi; Dariush Nasrollahzadeh; Shahryar Semnani; Farrokh Saidi; Christian C Abnet; Bruce Ponder; Paul D Pharoah; Nicholas E Day; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Reza Malekzadeh Journal: Arch Iran Med Date: 2013-01 Impact factor: 1.354
Authors: Nawfal R Hussein; Marjan Mohammadi; Yeganeh Talebkhan; Masoumeh Doraghi; Darren P Letley; Merdan K Muhammad; Richard H Argent; John C Atherton Journal: J Clin Microbiol Date: 2008-03-19 Impact factor: 5.948